22901451|t|Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse.
22901451|a|BACKGROUND: Perivascular macrophages and microglia are critical to CNS function. Drugs of abuse increase extracellular dopamine in the CNS, exposing these cells to elevated levels of dopamine. In rodent macrophages and human T-cells, dopamine was shown to modulate cellular functions through activation of dopamine receptors and other dopaminergic proteins. The expression of these proteins and the effects of dopamine on human macrophage functions had not been studied. METHODS: To study dopaminergic gene expression, qRT-PCR was performed on mRNA from primary human monocyte derived macrophages (MDM). Expression and localization of dopaminergic proteins was examined by immunoblotting isolated plasma membrane, total membrane and cytosolic proteins from MDM. To characterize dopamine-mediated changes in cytokine production in basal and inflammatory conditions, macrophages were treated with different concentrations of dopamine in the presence or absence of LPS and cytokine production was assayed by ELISA. Statistical significance was determined using two-tailed Students' T-tests or Wilcoxen Signed Rank tests. RESULTS: These data show that MDM express mRNA for all five subtypes of dopamine receptors, and that dopamine receptors 3 and 4 are expressed on the plasma membrane. MDM also express mRNA for the dopamine transporter (DAT), vesicular monoamine transporter 2 (VMAT2), tyrosine hydroxylase (TH) and aromatic amino acid decarboxylase (AADC). DAT is expressed on the plasma membrane, VMAT2 on cellular membranes and TH and AADC are in the cytosol. Dopamine also alters macrophage cytokine production in both untreated and LPS-treated cells. Untreated macrophages show dopamine mediated increases IL-6 and CCL2. Macrophages treated with LPS show increased IL-6, CCL2, CXCL8 and IL-10 and decreased TNF-alpha. CONCLUSIONS: Monocyte derived macrophages express dopamine receptors and other dopaminergic proteins through which dopamine may modulate macrophage functions. Thus, increased CNS dopamine levels due to drug abuse may exacerbate the development of neurological diseases including Alzheimer's disease and HIV associated neurological disorders.
22901451	37	42	human	Species	9606
22901451	54	66	dopaminergic	Disease	MESH:D009422
22901451	92	103	CNS disease	Disease	MESH:D002493
22901451	108	118	drug abuse	Disease	MESH:D019966
22901451	239	247	dopamine	Chemical	MESH:D004298
22901451	303	311	dopamine	Chemical	MESH:D004298
22901451	339	344	human	Species	9606
22901451	354	362	dopamine	Chemical	MESH:D004298
22901451	455	467	dopaminergic	Disease	MESH:D009422
22901451	530	538	dopamine	Chemical	MESH:D004298
22901451	542	547	human	Species	9606
22901451	609	621	dopaminergic	Disease	MESH:D009422
22901451	682	687	human	Species	9606
22901451	755	767	dopaminergic	Disease	MESH:D009422
22901451	898	906	dopamine	Chemical	MESH:D004298
22901451	960	972	inflammatory	Disease	MESH:D007249
22901451	1043	1051	dopamine	Chemical	MESH:D004298
22901451	1082	1085	LPS	Chemical	MESH:D008070
22901451	1434	1454	dopamine transporter	Gene	6531
22901451	1456	1459	DAT	Gene	6531
22901451	1462	1495	vesicular monoamine transporter 2	Gene	6571
22901451	1497	1502	VMAT2	Gene	6571
22901451	1505	1525	tyrosine hydroxylase	Gene	7054
22901451	1527	1529	TH	Gene	7054
22901451	1570	1574	AADC	Gene	1644
22901451	1577	1580	DAT	Gene	6531
22901451	1618	1623	VMAT2	Gene	6571
22901451	1650	1652	TH	Gene	7054
22901451	1657	1661	AADC	Gene	1644
22901451	1682	1690	Dopamine	Chemical	MESH:D004298
22901451	1756	1759	LPS	Chemical	MESH:D008070
22901451	1802	1810	dopamine	Chemical	MESH:D004298
22901451	1830	1834	IL-6	Gene	3569
22901451	1839	1843	CCL2	Gene	6347
22901451	1870	1873	LPS	Chemical	MESH:D008070
22901451	1889	1893	IL-6	Gene	3569
22901451	1895	1899	CCL2	Gene	6347
22901451	1901	1906	CXCL8	Gene	3576
22901451	1911	1916	IL-10	Gene	3586
22901451	1931	1940	TNF-alpha	Gene	7124
22901451	2021	2033	dopaminergic	Disease	MESH:D009422
22901451	2057	2065	dopamine	Chemical	MESH:D004298
22901451	2121	2129	dopamine	Chemical	MESH:D004298
22901451	2144	2154	drug abuse	Disease	MESH:D019966
22901451	2189	2210	neurological diseases	Disease	MESH:D020271
22901451	2221	2240	Alzheimer's disease	Disease	MESH:D000544
22901451	2245	2248	HIV	Disease	MESH:D015658
22901451	2260	2282	neurological disorders	Disease	MESH:D009461
22901451	Positive_Correlation	MESH:D008070	3586
22901451	Positive_Correlation	MESH:D004298	6571
22901451	Positive_Correlation	MESH:D008070	3576
22901451	Positive_Correlation	MESH:D004298	MESH:D019966
22901451	Positive_Correlation	MESH:D004298	6347
22901451	Positive_Correlation	MESH:D004298	MESH:D009461
22901451	Positive_Correlation	MESH:D004298	MESH:D020271
22901451	Positive_Correlation	MESH:D004298	MESH:D009422
22901451	Positive_Correlation	MESH:D008070	6347
22901451	Positive_Correlation	MESH:D004298	MESH:D000544
22901451	Positive_Correlation	MESH:D004298	MESH:D015658
22901451	Association	MESH:D008070	7124
22901451	Positive_Correlation	MESH:D004298	3569
22901451	Positive_Correlation	MESH:D008070	3569

